Know Cancer

or
forgot password

Effect of Omentectomy on Metabolic Syndrome, Acute Phase Reactants & Inflammatory Mediators in Patients Undergoing LRYGBP: A Randomized Trial


N/A
20 Years
65 Years
Not Enrolling
Both
Metabolic Syndrome, Morbid Obesity

Thank you

Trial Information

Effect of Omentectomy on Metabolic Syndrome, Acute Phase Reactants & Inflammatory Mediators in Patients Undergoing LRYGBP: A Randomized Trial


Although weight loss controls Metabolic Syndrome and reduces the level of inflammatory
markers in patients with Morbid Obesity, patients may enjoy the benefit achieving metabolic
control before significant weight loss occurs.


Inclusion Criteria:



- BMI > 35 Kg/m2

- Metabolic syndrome diagnosed

Exclusion Criteria:

- Type 1 diabetes

- Uncontrolled type 2 diabetes

- Cirrhosis or active hepatitis

- Pregnancy

- Recent MI or stroke

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Components of Metabolic Syndrome (Body Mass Index)

Outcome Time Frame:

Basal

Safety Issue:

Yes

Principal Investigator

Miguel F Herrrera, MD, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Authority:

Mexico: Ethics Committee

Study ID:

INCMNSZ-1486

NCT ID:

NCT00923260

Start Date:

December 2005

Completion Date:

July 2008

Related Keywords:

  • Metabolic Syndrome
  • Morbid Obesity
  • Omentectomy
  • metabolic syndrome
  • acute phase reactants
  • Obesity
  • Obesity, Morbid
  • Metabolic Syndrome X

Name

Location